News
Public · Published
Teladoc Health Q3 preview: Analysts see muted quarter as BetterHelp's performance weighs on results
Teladoc Health is expected to report soft third-quarter results on October 28 after the closing bell. Wall Street projects revenue to fall nearly 6% to $590.09M, within management's guidance range of $569M-$609M.
Published:
Updated:
What happened
Teladoc Health is expected to report soft third-quarter results on October 28 after the closing bell. Wall Street projects revenue to fall nearly 6% to $590.09M, within management's guidance range of $569M-$609M.
Confirmed
Global impact / market context
Weak revenue at Teladoc means less cash coming in to cover costs, and BetterHelp's cash-pay therapy model is struggling with fewer paying users, which pressures profit and makes future growth plans harder to fund.
Analyst inference
Analysts have cut earnings and revenue estimates sharply over three months, showing low expectations, while BetterHelp's decline in paying users and reset guidance signal a business model transition that weighs on the whole company's results.
Analyst inference
What to watch
- Watch whether third-quarter revenue lands within management's $569M-$609M guidance range and how far BetterHelp revenue falls after its 12% year-over-year drop last quarter. Confirmed
- Management may offer new details on the BetterHelp cash-pay model change; watch whether the company widens or narrows its full-year revenue guidance of $770M-$830M. Proposed
- Watch average monthly paying users at BetterHelp; another decline from 346,000 would suggest the therapy platform's customer losses are continuing and could pressure future revenue. Analyst inference